Elsie Oyoo
Investing Profile
Sweet spot: $1.5M
Range: $100K–$5M
2Flo Ventures thesis
Vivacelle Bio Vivacelle Bio leverages phospholipid nanoparticles treating relative (nitric oxide induced) and absolute hypovolemia due to septic or hemorrhagic shock. Temprian Therapeutics A biotech company focused on developing a safe and effective treatment for the skin depigmentation disease, Vitiligo. Delphian Therapeutics Delphian Therapeutics is a pioneer in FDA-approved, cannabinoid-based pain relief for hard-to-treat musculoskeletal and neurological conditions. Pain is commonly undertreated in patients of color and is shown to exacerbate adverse health outcomes. ResQ Pharma ResQ Pharma
Sector and stage focus
- Seed: LegalTech
- Series A: LegalTech
Is Elsie Oyoo a fit for your round?
Upload your pitch deck and see whether Elsie Oyoo appears in your top 20 matches.
Find investors for your deck